SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-21-131151
Filing Date
2021-10-28
Accepted
2021-10-28 17:21:01
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3/A tm2130817-1_s3a.htm S-3/A 210802
2 EXHIBIT 5.1 tm2130817d2_ex5-1.htm EX-5.1 12534
3 EXHIBIT 23.1 tm2130817d2_ex23-1.htm EX-23.1 3350
4 GRAPHIC image_001.jpg GRAPHIC 754
5 GRAPHIC lg_milestonepharm-4c.jpg GRAPHIC 83301
6 GRAPHIC tm2130817d2_ex5-1img001.jpg GRAPHIC 2382
7 GRAPHIC tm2130817d2_ex5-1img002.jpg GRAPHIC 3378
8 GRAPHIC tm2130817d2_ex23-1img002.jpg GRAPHIC 2789
9 GRAPHIC tm2130817d2_ex23-1img003.jpg GRAPHIC 5656
  Complete submission text file 0001104659-21-131151.txt   363988
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-257404 | Film No.: 211359535
SIC: 2834 Pharmaceutical Preparations